Free Trial
NASDAQ:VRPX

Virpax Pharmaceuticals (VRPX) Stock Price, News & Analysis

Virpax Pharmaceuticals logo
$0.01 0.00 (0.00%)
As of 08/8/2025 11:16 AM Eastern

About Virpax Pharmaceuticals Stock (NASDAQ:VRPX)

Key Stats

Today's Range
$0.0110
$0.0110
50-Day Range
$0.01
$0.46
52-Week Range
$0.01
$32.50
Volume
800 shs
Average Volume
176,953 shs
Market Capitalization
$13.66 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Receive VRPX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

VRPX Stock News Headlines

Virpax Pharmaceuticals Inc trading halted, news pending
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).
Virpax receives positive Probudur results for dose range study
Virpax Pharmaceuticals announces 1-for-25 reverse stock split
See More Headlines

VRPX Stock Analysis - Frequently Asked Questions

Virpax Pharmaceuticals' stock was trading at $9.4975 at the beginning of 2025. Since then, VRPX stock has decreased by 99.9% and is now trading at $0.0110.

Virpax Pharmaceuticals shares reverse split before market open on Friday, March 1st 2024.The 1-10 reverse split was announced on Friday, March 1st 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Virpax Pharmaceuticals (VRPX) raised $15 million in an IPO on Wednesday, February 17th 2021. The company issued 1,400,000 shares at a price of $10.00-$12.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

Shares of VRPX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Virpax Pharmaceuticals investors own include AMC Entertainment (AMC), Dare Bioscience (DARE), Rallybio (RLYB), Plug Power (PLUG), SNDL (SNDL) and SOS (SOS).

Company Calendar

Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VRPX
CIK
1708331
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.19 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-1,554.34%
Return on Assets
-338.29%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.13
Quick Ratio
0.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.65 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
1,242,000
Free Float
4,707,000
Market Cap
$13.66 thousand
Optionable
Not Optionable
Beta
1.49
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:VRPX) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners